AVXS Avexis, Inc. (delisted)

This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (April 10, 2018).

The Justice Department decided to allow Bayer's megadeal to acquire Monsanto after the firms pledged to sell off additional assets to secure antitrust approval.

Zuckerberg will tell lawmakers that Facebook failed to do enough to protect personal data from misuse and will lay out corrective steps.

Russian stocks plunged in the wake of new U.S. sanctions. Aluminum maker Rusal lost half its value.

Novartis agreed to buy gene-therapy firm AveXis for $8.7 billion, looking to refresh its drug pipeline.

PayPal has been offering some customers the option to add basic banking features to their digital wallets.

Alibaba is leading a $600 million funding round in a facial-recognition startup.

U.S. stocks pared gains after powering higher for much of the session. The Dow rose 46.34 points to 23979.10.

The NYSE opened its doors to stocks listed on rival exchanges, abandoning a decades-old policy.

Leucadia is selling assets to focus more on financial services and changing its name to Jefferies Financial.

The OCC's chief laid out plans to ease the application of banking regulations.

Apple said it achieved its goal of powering its facilities world-wide exclusively by renewable energy.

Uber agreed to buy on-demand electric-bike startup Jump Bikes.

(END) Dow Jones Newswires

April 10, 2018 02:47 ET (06:47 GMT)

Grafico Azioni AVEXIS, INC. (NASDAQ:AVXS)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni AVEXIS, INC. (NASDAQ:AVXS)
Storico
Da Giu 2023 a Giu 2024